Contact Information
Company Information
Company
OncoBeta - epidermal radioisotope therapy
Professional Summary
Nicholas Vetter serves as CEO and Managing Director (OncoBeta International GmbH) at OncoBeta - epidermal radioisotope therapy. OncoBeta - epidermal radioisotope therapy operates in the medical devices sector with approximately 35.0 employees. The company is headquartered in Munich, Bavaria.
Industry & Role Insights
-
•
MessageCEO tracks 1,888 executives in the medical devices sector.
-
•
1,671 executive contacts are available in Bavaria.
-
•
Our database includes 201,469 c suite-level executives.
Technologies
Cloudflare DNS
Outlook
CloudFlare Hosting
Google Tag Manager
Mobile Friendly
YouTube
Google Maps
Google Maps (Non Paid Users)
Keywords
nonmelanoma skin cancer treatment
brachytherapy
medical device
rhenium
basal cell carcinoma
squamous cell carcinoma
radioisotope
epidermal radioisotope therapy
skin cancer
medical equipment manufacturing
skin cancer therapy
non-melanoma skin cancer
rhenium-sct
painless treatment
non-invasive therapy
beta radiation
high-energy beta emitter
customized treatment
single-session therapy
aesthetic outcomes
treatment application system
oncobeta applicator
188re
188w generators
clinical safety
iso 13485 certification
tga approved
ce certified
patient quality of life
dermatology innovations
therapeutic applications
cancer treatment
minimal scarring
quick healing
risk management
care for elderly patients
treatment location
patient testimonials
effective skin cancer solutions
healthcare professionals
clinical partnerships
research & development
medical ethics
treatment costs
clinical trials
patient-centered care
treatment efficacy
improved recovery
medical regulations
outcomes improvement
therapeutic innovation
treatment education
skin cancer awareness
non-invasive solutions
hospital & health care
medical devices
health care
health
wellness & fitness
Related Executives
Outreach Guidance — medical devices Sector
Executives like Nicholas Vetter in the medical devices sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at OncoBeta - epidermal radioisotope therapy.
Nicholas Vetter's Position in the MessageCEO Database
- •Nicholas Vetter is 1 of 1 verified executive contact we track at OncoBeta - epidermal radioisotope therapy.
- •1,787 verified executive contacts in medical devices are in the MessageCEO database.
- •1,664 verified executive contacts in Bavaria are in the database.
- •22 verified contacts work at medical devices companies in the 35.0 employee range (same size as OncoBeta - epidermal radioisotope therapy).
Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.
Frequently Asked Questions
How do I reach Nicholas Vetter directly?
Nicholas Vetter's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO and Managing Director (OncoBeta International GmbH) at OncoBeta - epidermal radioisotope therapy. Access direct contact info to skip gatekeepers and reach the decision maker.
What company does Nicholas Vetter work for?
Nicholas Vetter is CEO and Managing Director (OncoBeta International GmbH) at OncoBeta - epidermal radioisotope therapy, a company in the medical devices sector with 35.0 employees. The company is based in Munich, Bavaria.
Can I pitch or sell to Nicholas Vetter?
As CEO and Managing Director (OncoBeta International GmbH) at OncoBeta - epidermal radioisotope therapy, Nicholas Vetter is a key decision-maker in the medical devices sector. MessageCEO Pro gives you verified email to reach Nicholas Vetter directly — ideal for B2B sales, partnerships, and executive recruiting.
What industry is Nicholas Vetter in?
Nicholas Vetter works in the medical devices industry as CEO and Managing Director (OncoBeta International GmbH) at OncoBeta - epidermal radioisotope therapy. MessageCEO provides verified contact information for executives across all major industries.
Is Nicholas Vetter's contact information verified?
Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Nicholas Vetter's profile is kept up-to-date with the latest available information.
Last updated: July 23, 2026
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans